.

By LACHLAN MOORHEAD

THE medication for an ultra-rare blood disease is still not guaranteed to be subsidised by the Federal Government despite a recent recommendation from the Pharmaceutical Benefits Advisory Committee (PBAC).
Soliris, the most effective treatment available for the rare atypical haemolytic uraemic syndrome (aHUS), was recommended by PBAC to be listed on the Pharmaceutical Benefits Scheme (PBS) at a meeting last month but pricing negotiations between the Federal Government and Soliris’ manufacturer Alexion Pharmaceuticals are still ongoing, with seemingly no end in sight.
Without subsidisation, Soliris is estimated to cost Australian patients roughly $500,000 a year.
Federal MP for La Trobe Jason Wood, who recently met again with nine-year-old aHUS sufferer Holly Van Der Loop and her Narre Warren family, said the process of having Soliris placed on the PBS was only half way.
“It’s great to hear that the PBAC has recommended Soliris to be listed on the PBS, news that we’ve been waiting to hear for a while now,” he said.
“Unfortunately though, we’re only about 50 per cent of the way through the process.
“A positive PBAC recommendation is a very important step in the listing process, but other steps need to be taken before a listing is achieved.
“Pricing negotiations, finalisation of the condition for listing, and quality and availability checks all have to be done before we can breathe a full sigh of relief.”
Holly was diagnosed with aHUS in October 2012, a life-threatening disease that can severely damage the kidneys, heart and brain, and which affects only two in one million Victorians.
Holly’s mother Linda thanked Mr Wood for pushing to have Soliris subsidised, and said the medication was currently beyond the reach of “everyday Australians”.
“I hope that it will be subsidised because if Holly needs it in the future, it’s something that a normal everyday family can’t afford,” she said.
While Holly’s condition has now stabilised, Linda is frighteningly aware of the rate of recurrence of the disease.
“I’m worried that every time she goes to school, she’ll contract an infection which could trigger another aHUS episode,” Linda said.
“I don’t know if Holly’s body could cope with another attack and having plasma exchange again.”
For more information, or to sign the aHUS Patient Support Group Australia petition, visit www.ahus.com.au

Comments are closed.

Your first stop before buying a home. View the whole picture.

More News

Free lessons, games and social tennis are being served up for the return of Casey Tennis Week. Drawing on the ...

 Virtual reality technology is about to breathe new life into the humble exercise bike at Casey ARC. In what ...

A woman from Berwick has burst into tears upon hearing confirmation she won more than $1.4 million in TattsLotto’s $30 ...

Casey in Colour There will be a different code of racing at the Cranbourne Turf Club this month as thousands ...

Narre Warren South grandmother Jennifer Marshall has arrived home after spending the last seven weeks volunteering on board the Africa ...

Road works have started on Narre Warren-Cranbourne Road, Narre Warren, between Norfolk Drive and the 7-Eleven Service Station. The work ...

Latest Sport

It’s not unusual to see a century next to Steven Spoljaric’s name on the scorecard – but when the ...

Every single season, the DDCA’s Turf 1 competition continually raises the bar in quality – this year is no different. With ...

Berwick Little Athletics’ stars of today have the world at their feet and gave a glimpse recently into just what ...